cough, followed by shortness of breath and left anterior chest pain, in May 1990. A chest radiograph showed bilateral lower lobe minimal pneumonia. Bronchoscopy specimens were negative for P. carinii, fungi, and bacteria. However, multiple acid-fast organisms were identified from a transbronchial biopsy from the superior segment of the right upper lobe, obtained because of a nodular intrabronchial lesion seen on bronchoscopy. Cultures of the biopsy grew a Mycobacterium sp. subsequently identified as niacin-positive M. kansasii. Initially, he was treated with clofazimine, ethambutol, rifampin, and ciprofloxacin for presumed Mycobacterium avium complex infection. After identification of the mycobacterial isolate, his therapy was changed to INH, ethambutol, and rifampin. At present, the patient is doing well clinically and remains on therapy.
Case 3 (University of Cincinnati). A 51-year-old black man received his second cadaveric kidney transplant in August 1978. In July 1989, he developed significant weight loss, low-grade fever, night sweats, and pain around the rectum. The patient was negative for HIV antibody. A CT scan showed a small perirectal fluid collection, but no action was taken because symptoms improved. In November 1989, he experienced additional weight loss and generalized malaise. A repeat CT scan revealed a massive pelvic fluid collection and the appearance of a large perirectal abscess. Pus drained surgically from his perirectal abscess showed numerous acid-fast bacilli, which grew a Mycobactenum sp. identified as niacin-positive M. kansasii. He was treated with INH, rifampin, ethambutol, and prednisone after surgery. The surgical wound healed in an expected fashion and eventually closed without incident. Antimycobacterial therapy and maintenance immunosuppressive therapy have continued to the present, and the patient remains well.
Specimens at both institutions were processed by using the N-acetyl-L-cysteine-NaOH technique (11, 13) ing was performed by the paper strip method (Difco, Detroit, Mich.). All specimens examined from these patients showed the presence of acid-fast bacilli by fluorochrome staining. A number of biochemical and growth studies were performed on the isolates (Table 1) . Growth on primary media was noted after 2 1/2 to 3 weeks of incubation, and colonies exhibited photochromogenicity. Tests for niacin accumulation on all isolates were positive. Several biochemical tests, including nitrate reduction and semiquantitative catalase tests, were useful in distinguishing our isolates from Mycobactenium maninum, and in addition, Tween hydrolysis and arylsulfatase tests were helpful in distinguishing the isolates from Mycobactenium simiae. Growth temperature studies are also useful for distinguishing M. kansasii from M. maninum. The isolates were tested for susceptibility to INH, ethambutol, streptomycin, and rifampin by the proportion method of susceptibility (13) . All three isolates were partially INH resistant at 0.2 ,ug/ml, ethambutol susceptible (5.0 ,ug/ml), and rifampin susceptible (1.0 ,ug/ml). All isolates were susceptible to streptomycin at 10 ,ug/ml, but only two of the three were susceptible to streptomycin at 2.0 ,ug/ml. Additional confirmatory tests were performed. M. kansasii produces a unique N-acylamino sugar in the lipooligosaccharide, named N-acylkansosamine (7), and is unique among the different mycobacterial species. By using thinlayer chromatography, the lipooligosaccharides isolated from our three isolates were shown to be alkali labile, gave a thin-layer chromatography pattern consistent with M. kansasii, and, by using a specific monoclonal antibody directed against N-acylkansosamine, also reacted in an enzyme-linked immunosorbent assay (ELISA) (4, 8) . Intact lipid was used in an ELISA using a monoclonal antibody directed against N-acylkansosamine (8) with ELISA optical density values ranging from 0.986 to >2.0. Lipid derived from a negative control strain, M. avium complex, showed a negative reaction.
Niacin-positive M. kansasii have been reported only twice in the literature, during the 1960s. Yue give a positive reaction but can be differentiated from M. kansasii on the basis of growth temperature studies and selected biochemical tests (11) . M. kansasii also contains an alkali-labile lipooligosaccharide (3) . A unique, N-acylamino sugar epitope is present in M. kansasii which was described by Hunter et al. (7, 8) and detected in our isolates by ELISA. M. tuberculosis, Mycobacterium bovis, M. simiae, and M. marinum do not contain this epitope.
Infection with M. kansasii is common in immunocompromised patients and is thought to be the second most common nontuberculous mycobacterial infection in patients with AIDS (9) . Of interest is a recent report of 19 AIDS patients with M. kansasii infection in which it was found that 6 patients had concurrent P. carinii infections, similar to the situation of one of our patients. The finding of cavitary disease in case 1 is consistent with its role as a significant pathogen and is a good predictor of M. kansasii disease in patients without AIDS (1). M. kansasii has been reported to cause abscesses in patients with underlying immunodeficiency, such as in HIV infection (12) and renal transplantation (5) . Although M. kansasii has been isolated from different body sites, case 3 is the first reported instance, to our knowledge, of M. kansasii causing a perirectal abscess.
The susceptibility patterns of the three isolates were consistent with those of the usually niacin-negative M. kansasii strains. This finding and the fact that antimicrobial therapy was effective in our patients suggest that niacin positivity was not associated with any change in the virulence of the organisms. It is interesting that there was a two-decade lapse between the original descriptions of niacinpositive M. kansasii and our observations. At 
